Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.98 USD | +0.97% | -0.23% | -11.18% |
26/02 | Stepan Insider Sold Shares Worth $913,105, According to a Recent SEC Filing | MT |
20/02 | Stepan's Q4 Adjusted Earnings, Net Sales Fall | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company benefits from high valuations in earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.18% | 1.88B | B+ | ||
+11.47% | 63.22B | A- | ||
-2.41% | 46.34B | A- | ||
+13.78% | 39.97B | B+ | ||
+17.83% | 25.46B | A- | ||
+7.71% | 18.68B | C+ | ||
-0.57% | 17.24B | B+ | ||
-21.73% | 15.81B | A- | ||
+1.21% | 14.9B | B+ | ||
-19.10% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SCL Stock
- Ratings Stepan Company